Cite
HARVARD Citation
Bramlage, P. et al. (2015). The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry. Trials. 16 (1), pp. 1-9. [Online].